News | Mammography | November 21, 2018

Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA

Company will show off cloud-based quantitative breast imaging analysis tools, host speaker series

Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA

November 21, 2018 — Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological Society of North America (RSNA) meeting, Nov. 25–30 in Chicago. Its suite of cloud-based quantitative breast imaging analysis tools is designed to help maintain consistent quality in breast screening.

This year, Volpara will launch the VolparaLive! system, mammography's first real-time decision support system at the point of care. The VolparaLive! system automatically analyzes patient positioning and compression to help technologists acquire consistent, high-quality mammograms. One of the key benefits of the system is the cost reduction of fewer technical recalls, made possible by providing technologists with actionable data before the patient leaves the room.

Major improvements to the VolparaEnterprise software will be demonstrated for the first time:

  • A new reporting function for periodic image quality reviews further streamlines Enhancing Quality Using the Inspection Program (EQUIP) compliance and the image quality review process;
  • Users can generate a list of exams based on the VolparaEnterprise quality assessment for periodic image quality reviews, sorting by interpreting physicians and technologists; and
  • The software now features vPGMI, a new image positioning quality standard, according to Volpara.

This year, Volpara will host a distinguished speaker series at RSNA, including:

  • Prof. Jack Cuzick: Volpara and Risk Assessment: Importance of Volumetric Density in TC8
    • Director, Wolfson Institute of Preventive Medicine; Head, Centre for Cancer Prevention and John Snow Professor of Epidemiology, Queen Mary University of London
  • JoAnn Pushkin: Breast Density Legislation and Education – US and Europe
    • Executive Director, DenseBreast-Info.org
  • Prof. Sir Mike Brady: How AI and Machine Learning Can Impact Mammography
    • Professor of Oncological Imaging, University of Oxford
  • Amy Chatten, MPH, Measuring the Impact of Hands-On Technologist Training on Mammographic Image Quality
    • Executive Director, Mammography Educators, LLC

 

For more information: www.volparasolutions.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
CT image of Novel Coronavirus 2019-nCoV from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

An image from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

Feature | Computed Tomography (CT) | February 11, 2020
February 11, 2020 — The Radiological Society of North America (RSNA) jo
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth
Carestream mobile Xray
News | Digital Radiography (DR) | February 08, 2020
February 8, 2020 — Carestream Health was awarded 37 new paten
An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
Sponsored Content | Videos | Artificial Intelligence | February 07, 2020
At RSNA19, GE Healthcare introduced its...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Coronovirus eipidemic 2019-nCoV. CT lung imaging from a 41-year-old woman who tested positive for the 2019 novel coronavirus (2019-nCoV). This 3-D reconstruction shows multifocal ground glass opacities without consolidation. Coronavirus medical imaging example. Corona virus CT and nCoV 2019 presentation on CT medical imaging.

CT lung imaging from a 41-year-old woman who tested positive for the 2019 novel coronavirus (2019-nCoV). This 3-D reconstruction shows multifocal ground glass opacities without consolidation. See also three-dimensional VIDEO of this rendering.
 

News | Computed Tomography (CT) | February 05, 2020
February 5, 2020 — In a special report published in the journal ...